MSI: Plasma-activated antimicrobial hydrogel therapy (PAHT) for combatting infections in diabetic foot ulcers - Research Portal | Lancaster University

Home > Research > Projects > MSI: Plasma-activated antimicrobial hydrogel th...

View graph of relations

MSI: Plasma-activated antimicrobial hydrogel therapy (PAHT) for combatting infections in diabetic foot ulcers

Project: Research

Status	Active
Effective start/end date	1/02/21 → 31/10/24

Funding

EPSRC: £505,741.22
EPSRC: £34,200.92
EPSRC: £4,242.73
EPSRC: £24,145.13

Jaki, Thomas (Co-Investigator)
Mateus, Ceu (Co-Investigator)
Hollingsworth, Bruce (Co-Investigator)
Allinson, Sarah (Co-Investigator)
Short, Robert (Principal Investigator)

Research outputs

On-demand cold plasma activation of acetyl donors for bacteria and virus decontamination
Research output: Contribution to Journal/Magazine › Journal article › peer-review
The influence of a second ground electrode on hydrogen peroxide production from an atmospheric pressure argon plasma jet and correlation to antibacterial efficacy and mammalian cell cytotoxicity
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Cold Plasma Generation of Peracetic Acid for Antimicrobial Applications
Research output: Contribution to Journal/Magazine › Journal article › peer-review
On Plasma Activated Acetyl Donors: Comparing the Antibacterial Efficacy of Tetraacetylethylenediamine and Pentaacetate Glucose
Research output: Contribution to Journal/Magazine › Journal article › peer-review